com after supplementation showed a decreasing trend in the percent CD4+ CD45RO+ memory T-cells post-supplement (Fig. 4 B, Pearson’s correlation = 0.51, p = 0.061), and an increasing trend in the percent CD4+ CD45RA+ naïve T-cells post-supplement (Fig. 4 C, Pearson’s correlation = 0.50, p = 0.060), and a significantly lower CD4+ CD45RO+: CD4+ CD45RA+ T-cell ratio after supplementation (Fig. 4 D, Pearson’s correlation = 0.67, p = 0.008).
← all phrases
“a decreasing trend”
Sighted at
p=0.09
In the literature
A decreasing trend in the filled-grain percentage ( p = 0.061) was detected for the duckweed coverage. 2.2.
Similarly, when the agreeableness score increased, the likelihood of a suicide attempt in the NIT group had a decreasing trend (OR = 0.332; p = .061), whereas that of the IT group increased (OR = 2.425).
3 D) were lower in the golimumab group than in the etanercept group; meanwhile, the sting level showed a decreasing trend (without statistical significance) in the golimumab group than in the etanercept group ( P = .061, Fig. 3 E).
Furthermore, TFAC-H also inhibited the mRNA expression of COX-2 ( P = 0.002) and showed a decreasing trend to LOX-12 ( P = 0.061) and LOX-15 ( P = 0.099; Fig. 2 B).
Additionally, ALT/AST ratio, ALB, and TAA levels were significantly higher in the HSTG group ( P < 0.05), with ALT showing an increasing trend ( P = 0.061) and AST showing a decreasing trend ( P = 0.062).
Limb shortening resulting from knee flexion showed a decreasing trend ( p = 0.061) but did not reach statistical significance.
For the elderly with some level of depression ( Figure 9 ), triple-positive cells for CD14+CD80+CD86+ showed a decreasing trend ( p = 0.0611) ( Figure 9(a) ).
VDAC3 expression increased significantly across stages (ANOVA, p = 0.0129), whereas VDAC2 showed a decreasing trend (ANOVA, p = 0.0612), and VDAC1 did not vary significantly by stage (ANOVA, p = 0.589) ( Figure 1 D–F).
During the intervention, NEMG of lTES1, rTES, lLES and rLES showed a decreasing trend in the last 10 min by comparison with the first 10 min (−58%, p = 0.062; −13%, p = 0.577; −6%, p = 0.829 and −60%, p = 0.021 respectively).
ATNR-Quad-L also showed a decreasing trend ( p = 0.062).
However, nuclear RUNX2 staining showed a decreasing trend in the pericalcification areas ( p -value = 0.062) ( Figure 1 C,D and Supplementary Figure S1B ).
Changes in HbA1c and FBG from baseline among the different 4 groups Administration of dapagliflozin was found to reduce HbA1c significantly after 6 months by 1 percentage point (p = 0.045) and showed a decreasing trend after 12 months of 1.5 percentage points (p = 0.062).
2 D), while the concentration of MDA showed a decreasing trend ( P = 0.062; Fig. 2 E).
In contrast, alpha diversity only showed an increasing trend ( P = 0.062) at week 4 in P‐type patients, and this trend was only temporary, as both alpha diversity ( P = 0.062) and strain richness ( P = 0.062) showed a decreasing trend by week 12 (Figure 3A ).
A change in treatment from another ARB to irbesartan resulted in a decrease in hs-CRP (2.80 ± 0.53 versus 2.66 ± 0.50 log(ng mL −1 )) and d-ROMs (338 ± 74 versus 305 ± 62 U.CARR; p < 0.001); there was also a decreasing trend in the proteolytic enzyme released from inflammatory cells, MMP-9 (1.03 ± 0.86 versus 0.62 ± 0.59 mg mL −1 ; p = 0.062) and MPO (1.50 ± 0.70 versus 0.51 ± 0.43 IU mL −1 ; p = 0.057), which plays a role in oxidative and inflammatory processes.
Hepatic Lipid Contents, and Gene Expression in the Liver and Intestine Clostridium butyricum treatment had no significant impacts ( P > 0.10) on the contents of total lipid, TC and FFAs in the liver of birds ( Table 4 ), but led to a decreasing trend ( P = 0.062) of TG content with significantly reduced ( P < 0.05) contents of FFAs in the liver.
Cystatin C, as a marker of kidney function independent of muscle mass, showed no significant difference before or after the PCR-diet nor postoperatively; however, concentrations of Cystatin C did show on average a decreasing trend in PCR-donors on POD3 compared to controls ( P =0.062, Figure 1E ).
792 (562–1,025) ng/ml; P = 0.02], and the sCD163/sTWEAK ratio showed a decreasing trend [2.88 (2.37–3.85) vs. 2.44 (1.42–3.2); P = 0.062] after ART ( Figure 1 ).
dd-cfDNA fraction measured pre - and post - intervention demonstrated a decreasing trend in the state of molecular injury: 3.24% (IQR, 1.675–8.71) vs. 0.75% (0.165–1.825; p = 0.0625), respectively.
At baseline, there was a decreasing trend in gray matter (GM) CBF with an increase of WMH burden (P=0.063), but this association was attenuated after adjusting for age (P=0.362).
Compared with the control group, the F/G of broilers during the 22–42 days phase in the PT1 group showed a decreasing trend ( P = 0.063).
The number of GFAP+ cells produced showed a decreasing trend from 2 to 18 months in males (p = 0.063; Figure 7 F).
Although FOXP3+ T cells showed a decreasing trend in the high-expression group, the difference did not reach statistical significance ( p = 0.063).
Whereas, we found that when the expression value of ANLN 210 increased, the patient’s survival period only showed a decreasing trend ( P = 0.063, Fig. 1F ).